Barely Significant
← all excerpts

Dual-site spatiotemporal and simultaneous inhibition on PIN1 via arsenic-retinoic albumin nanoparticles enables synergistic oncotherapy.

J Nanobiotechnology · 2025 · PMC12837326 · PMID 41437379

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

highly significantP < 0.01actually significant
The mean differences were considered significant for * P < 0.05, and highly significant for ** P < 0.01, *** P < 0.001, or **** P < 0.0001.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.